Atlas Trials

3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects

Clinical trial NCT00312494 · COMPLETED

Trial details

NCT number
NCT00312494
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bipolar Disorder
Start date
2006-04-01
Primary completion
2008-12-01
Enrollment
680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.